Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runqiu Jiang

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Oncotarget|April 1, 2015
The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cellsXin Wan, Ci Cheng, Zhe Lin, et al.
Cancer Letters|November 17, 2019
Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinomaQing Li, Jiannan Qiu, Hui Yang, et al.
Clinical & Developmental Immunology|October 5, 2011
Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vectorDongchang Yang, Qing Shao, Hua Sun, et al.
Journal of Molecular Cell Biology|June 29, 2015
PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinomaJiajie Hou, Lei Deng, Han Zhuo, et al.
Oncotarget|April 1, 2015
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesisWenjie Zhang, Jiajie Hou, Xiaochen Wang, et al.
Oncogene|October 30, 2019
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarizationGuolong Xu, Dongju Feng, Yao Yao, et al.
Nature Communications|May 26, 2017
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasionRunqiu Jiang, Junwei Tang, Yun Chen, et al.
Cellular & Molecular Immunology|May 21, 2013
A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinomaChen Chen, Jiajie Hou, Zhe Lin, et al.
BMC Cancer|February 6, 2013
IL-22 is related to development of human colon cancer by activation of STAT3Runqiu Jiang, Haiyang Wang, Lei Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 9, 2025
Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD-MASH Transition by Disrupting Carnitine BiosynthesisSenlin Lian, Meixi Lu, Luo Jiajing, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Oncotarget|April 1, 2015
The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cellsXin Wan, Ci Cheng, Zhe Lin, et al.
Cancer Letters|November 17, 2019
Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinomaQing Li, Jiannan Qiu, Hui Yang, et al.
Clinical & Developmental Immunology|October 5, 2011
Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vectorDongchang Yang, Qing Shao, Hua Sun, et al.
Journal of Molecular Cell Biology|June 29, 2015
PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinomaJiajie Hou, Lei Deng, Han Zhuo, et al.
Oncotarget|April 1, 2015
PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesisWenjie Zhang, Jiajie Hou, Xiaochen Wang, et al.
Oncogene|October 30, 2019
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarizationGuolong Xu, Dongju Feng, Yao Yao, et al.
Nature Communications|May 26, 2017
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasionRunqiu Jiang, Junwei Tang, Yun Chen, et al.
Cellular & Molecular Immunology|May 21, 2013
A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinomaChen Chen, Jiajie Hou, Zhe Lin, et al.
BMC Cancer|February 6, 2013
IL-22 is related to development of human colon cancer by activation of STAT3Runqiu Jiang, Haiyang Wang, Lei Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 9, 2025
Conjugated Lithocholic Acid Activates Hepatic TGR5 to Promote Lipotoxicity and MASLD-MASH Transition by Disrupting Carnitine BiosynthesisSenlin Lian, Meixi Lu, Luo Jiajing, et al.
Pageof 8